Innovative agreements: Exploring alternative payment models

Healthcare payers and biopharma companies have increasingly adopted innovative agreements, such as outcomes-based contracts, disease management programs, and subscription models, which aim to improve health outcomes and/or reduce cost. As the industry drives towards value-based pricing, a growing emphasis is being placed on novel payment models, especially for cell and gene therapies.

Watch today to learn:

• What really matters to payers?
• What are the most common drivers?
• The key elements in successful partnerships
• Upcoming financial products for cell and gene therapies

Enter your information below to access the webinar on demand.